TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31140343

Group type: EXPERIMENTAL
Intervention: NT-proBNP intervention in the intervention group (34 GP practices)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group (35 GP practices)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: NT-proBNP intervention in the intervention group
Number of subjects: 700
Study: 29733770

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 320
Study: 26671216

Group type: EXPERIMENTAL
Intervention: Robot only (60 minutes of robotic therapy)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Robot + TTT (45 minutes on the robot plus 15 minutes of translation‐to‐task practice)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Robot only
Number of subjects: 22

Group type: COMPARATOR
Intervention: Robot + TTT
Number of subjects: 22
Study: 25214041

Group type: EXPERIMENTAL
Intervention: biCEBPA mutations
Number of subjects: 88

Group type: COMPARATOR
Intervention: moCEBPA mutations
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: biCEBPA mutations in patients ≤ 60 years
Number of subjects: 88
Study: 22898992

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg, single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium Nitroprusside (1 ‐ 2 µg/kg/min)
Number of subjects: 0
Study: 20100120

Group type: EXPERIMENTAL
Intervention: 0.2% NaF mouthwash
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.1% NaF toothpaste
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.5% NaF-impregnated Miswaks
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.32% NaF toothpaste
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.05% NaF mouthwash
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.05% NaF-impregnated Miswaks
Number of subjects: 9
Study: 17299109

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (laparoscopic Roux-en-Y gastric bypass, n = 21; laparoscopic adjustable gastric banding, n = 5)
Number of subjects: 26
Study: 15611850

Group type: EXPERIMENTAL
Intervention: Hypnotherapeutic treatment program (n=10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control condition (n=11)
Number of subjects: 21
Study: 12218617

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) with 60 microg and 100 mg hydrocortisone for 7 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo with 100 mg hydrocortisone
Number of subjects: 57
Study: 10624762

Group type: EXPERIMENTAL
Intervention: Methacholine challenge (concentration up to 128 mg x mL(‐1))
Number of subjects: 8
Study: 7496872

Group type: EXPERIMENTAL
Intervention: Erythromycin (150 mg/h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2044501

Group type: EXPERIMENTAL
Intervention: Felbamate (FBM) 50 mg/kg per day (maximum 3,000 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7019201

Group type: EXPERIMENTAL
Intervention: Single daily doses of amoxapine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Divided daily doses of amoxapine
Number of subjects: 35
Study: 31229956

Group type: EXPERIMENTAL
Intervention: Lower SpO2 target (85%-89%)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Higher SpO2 target (91%-95%)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation duration
Number of subjects: 984

Group type: COMPARATOR
Intervention: Other risk factors
Number of subjects: 984
Study: 29485926

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 13347

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13347
Study: 27108543

Group type: EXPERIMENTAL
Intervention: Passive pedaling exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Active pedaling exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pedaling (both passive and active)
Number of subjects: 10
Study: 25197921

Group type: EXPERIMENTAL
Intervention: Aerosolized fibrin sealant (FS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Polyvinyl acetal sponge packing
Number of subjects: 41
Study: 23033003

Group type: EXPERIMENTAL
Intervention: Therapy (specifics not provided)
Number of subjects: 0
Study: 21137794

Group type: EXPERIMENTAL
Intervention: LF-SQ cream applied twice daily on one half of the face
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: LF-SQ cream
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (squalane blended cream without fullerene-C60)
Number of subjects: 23
Study: 18201449

Group type: EXPERIMENTAL
Intervention: Rabeprazole, 20 mg, orally twice daily for 90 days
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 15797496

Group type: EXPERIMENTAL
Intervention: Low dose pulsed shortwave (10 W)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High dose pulsed shortwave (20 W)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo high frequency pulsed shortwave
Number of subjects: 27
Study: 12372721

Group type: EXPERIMENTAL
Intervention: Systemic adjuvant chemotherapy
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hepatic-artery-based chemotherapy or embolisation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Other therapeutic modalities (immunological, radiation, differentiation agents)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Adjuvant systemic chemotherapy
Number of subjects: 13
Study: 9657512

Group type: EXPERIMENTAL
Intervention: CGP 56697
Number of subjects: 260

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 260
Study: 7977112

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 204

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 204
Study: 2686455

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptives (1) ethinyl estradiol 30, 40, 30 micrograms/day and levonorgestrel 50, 75, 125 micrograms/day; (2) ethinyl estradiol 35 micrograms/day and phased norethindrone 500, 750, 1000 micrograms/day; (3) ethinyl estradiol 35 micrograms/day and norethindrone 500, 1000, 500 micrograms/day
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (nonhormonal contraception)
Number of subjects: 150
Study: 31734734

Group type: EXPERIMENTAL
Intervention: Probiotic product (Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2) 109 CFU once daily for 3 months
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Probiotic product
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Probiotic product (projected data)
Number of subjects: 131
Study: 29332761

Group type: EXPERIMENTAL
Intervention: Physical exercise intervention in Group 1 (symptomatic knee OA)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Physical exercise intervention in Group 2 (asymptomatic knee OA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No intervention in Group 3 (control group)
Number of subjects: 42
Study: 26643066

Group type: EXPERIMENTAL
Intervention: 38Checkpain checklist for pain control
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard practice without the 38Checkpain checklist
Number of subjects: 92
Study: 24356798

Group type: EXPERIMENTAL
Intervention: Multimodal method (MMM) using indocyanine green (ICG), radioisotope (RI), and blue dye (BD)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Radioisotope (RI) alone
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Multimodal method (MMM)
Number of subjects: 86
Study: 22319592

Group type: EXPERIMENTAL
Intervention: Doxazosin (1 mg PO/day, increased every three days by 1 mg up to 4 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (matched placebo lactose)
Number of subjects: 13
Study: 20521064

Group type: EXPERIMENTAL
Intervention: EAA supplementation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: EAA group
Number of subjects: 29
Study: 18394742

Group type: EXPERIMENTAL
Intervention: Functional retraining programme with daily isokinetic reinforcement of the trunk muscles
Number of subjects: 60

Group type: COMPARATOR
Intervention: Functional retraining programme without daily isokinetic reinforcement of the trunk muscles (Control Group)
Number of subjects: 60
Study: 16107596

Group type: EXPERIMENTAL
Intervention: Taurine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No taurine supplementation (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taurine supplementation in infants with necrotizing enterocolitis (NEC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No taurine supplementation in infants with necrotizing enterocolitis (NEC) (Control)
Number of subjects: 0
Study: 14534891

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg)
Number of subjects: 1648

Group type: COMPARATOR
Intervention: Pamidronate (90 mg)
Number of subjects: 1648
Study: 11012611

Group type: EXPERIMENTAL
Intervention: Treatment of pulmonary TB for 6 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Asthma patients (no treatment)
Number of subjects: 49
Study: 8858276

Group type: COMPARATOR
Intervention: Atenolol (50 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg)
Number of subjects: 17
Study: 7678931

Group type: EXPERIMENTAL
Intervention: finasteride 1 mg/day and finasteride 5 mg/day (combined results)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 29683919

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Current exercise guidelines (30 min·d moderate-intensity exercise)
Number of subjects: 250
Study: 28144978

Group type: EXPERIMENTAL
Intervention: Team training (TG)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Resistance training (RG)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 72
Study: 27193736

Group type: EXPERIMENTAL
Intervention: Anticipatory guidance on protective feeding practices
Number of subjects: 698

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 698
Study: 23574097

Group type: EXPERIMENTAL
Intervention: Memory-rich teaching
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low memory instruction
Number of subjects: 54
Study: 21467697

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC, 705 mg orally before and 12, 24, 36 hours after primary angioplasty)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: N-acetylcysteine (NAC) and Placebo
Number of subjects: 76
Study: 19525846

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg daily)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Simvastatin (10 mg daily)
Number of subjects: 135
Study: 16461864

Group type: EXPERIMENTAL
Intervention: Incentive group (n = 198) with abstinence incentives during a 12-week trial.
Number of subjects: 388

Group type: COMPARATOR
Intervention: Usual care group (n = 190) without abstinence incentives during a 12-week trial.
Number of subjects: 388
Study: 15505610

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide, carmustine, and thiotepa (CBT) followed by autologous hematopoietic stem cell transplantation (AHST)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: High-dose CBT followed by AHST
Number of subjects: 177
Study: 11775651

Group type: EXPERIMENTAL
Intervention: Essaven gel (EG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8712429

Group type: EXPERIMENTAL
Intervention: Enflurane (0.5%, 0.8%, or 1.1% end‐tidal) in N2O (66% end‐tidal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enflurane (1.1% end‐tidal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Return of consciousness
Number of subjects: 12
Study: 1888641

Group type: EXPERIMENTAL
Intervention: Cromakalim 2.0 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cromakalim 1.0 mg and 2.0 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6669636

Group type: EXPERIMENTAL
Intervention: 2.5 mg zopiclone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5 mg zopiclone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg zopiclone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30661639

Group type: EXPERIMENTAL
Intervention: Customized 10-item short form (EF10)
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Common EORTC Quality of Life Questionnaire Core 30 four-item scale (EF4)
Number of subjects: 1028
Study: 28285042

Group type: EXPERIMENTAL
Intervention: Interaction with a highly capable adult in half of the dialogs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peer-only dialogs
Number of subjects: 0
Study: 25560444

Group type: EXPERIMENTAL
Intervention: Strict rest for 5 days
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care (1‐2 days rest, followed by stepwise return to activity)
Number of subjects: 99
Study: 23726161

Group type: EXPERIMENTAL
Intervention: Inactivated alum-adjuvant EV71 vaccine
Number of subjects: 10245

Group type: COMPARATOR
Intervention: Alum-adjuvant placebo
Number of subjects: 10245
Study: 21897013

Group type: EXPERIMENTAL
Intervention: Astaxanthin supplementation 1 mg/d for 4 or 12 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Astaxanthin supplementation 3 mg/d for 4 or 12 weeks
Number of subjects: 20
Study: 20046641

Group type: EXPERIMENTAL
Intervention: High fat meal
Number of subjects: 30
Study: 17711716

Group type: COMPARATOR
Intervention: Regional longitudinal ventricular systolic velocities (R1is, R2is, R2ez, R3is, S1is, S1ez, S2ez, L1is, L1ez, L2ez) in group A (patients with cardiac events)
Number of subjects: 42

Group type: COMPARATOR
Intervention: VO(2max)
Number of subjects: 42
Study: 15507582

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT) alone
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Sertraline alone
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combined CBT and sertraline
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 12102584

Group type: EXPERIMENTAL
Intervention: Habit reversal treatment in a minimal therapist contact (MTC) format
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 20
Study: 9158630

Group type: EXPERIMENTAL
Intervention: HMG-CoA reductase inhibitors (statins)
Number of subjects: 20438

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20438
Study: 8129214

Group type: EXPERIMENTAL
Intervention: Theo-24 (800 mg daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Theo-Dur (800 mg daily)
Number of subjects: 16
Study: 2914061

Group type: EXPERIMENTAL
Intervention: Sleep deprivation for 24 hours
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sleep deprivation for 34 hours
Number of subjects: 45
Study: 1093461

Group type: EXPERIMENTAL
Intervention: mini-dose heparin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: radiopharmaceutical imaging technique with 99m-technetium macroaggregated albumin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: perfusion lung study
Number of subjects: 150
Study: 31327131

Group type: EXPERIMENTAL
Intervention: Resveratrol 800 mg/day for 40 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo for 40 days
Number of subjects: 62
Study: 28724799

Group type: EXPERIMENTAL
Intervention: Galantamine 8 mg daily for 4 weeks, followed by 16 mg daily for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25239489

Group type: EXPERIMENTAL
Intervention: Continued cognitive-behavior therapy (CBT) for 16 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sertraline (SRT) for 16 weeks
Number of subjects: 54
Study: 24373281

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 70
Study: 22115874

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily
Number of subjects: 20536

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20536

Group type: EXPERIMENTAL
Intervention: Combined in-trial and post-trial periods
Number of subjects: 20536
Study: 19896079

Group type: EXPERIMENTAL
Intervention: Infliximab + methylprednisolone (MP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Infliximab + MP
Number of subjects: 63

Group type: COMPARATOR
Intervention: MP
Number of subjects: 63
Study: 16827823

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 1200

Group type: COMPARATOR
Intervention: All groups (Expectant, Medical, Surgical)
Number of subjects: 1200
Study: 15370080

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (betamethasone)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 10840082

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9338926

Group type: EXPERIMENTAL
Intervention: Non-steroid treated patients
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Steroid treated patients
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Patient group
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Multiple linear regression model
Number of subjects: 85
Study: 8450996

Group type: EXPERIMENTAL
Intervention: Prednisone (0.75 mg/kg/d)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combination therapy (Prednisone 0.3 mg/kg/d and Azathioprine 2.5 mg/kg/d)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Azathioprine (2.5 mg/kg/d)
Number of subjects: 37
Study: 3743416

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 263

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 263

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 263
Study: 29494867

Group type: EXPERIMENTAL
Intervention: Karolinska Interpersonal Violence Scale (KIVS)
Number of subjects: 106
Study: 27184636

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 mg twice a day (Group A)
Number of subjects: 250

Group type: COMPARATOR
Intervention: UDCA 300 mg twice a day (Group B)
Number of subjects: 250
Study: 24332892

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both conditions (MPH and placebo)
Number of subjects: 16
Study: 23013141

Group type: EXPERIMENTAL
Intervention: Web-based brief intervention (web-BI)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 800
Study: 20465444

Group type: EXPERIMENTAL
Intervention: Bevel-up insertion (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bevel-down insertion (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MVR blade insertion (group 3)
Number of subjects: 60
Study: 17335298

Group type: EXPERIMENTAL
Intervention: Insulin lispro (Humalog)
Number of subjects: 0
Study: 15821693

Group type: EXPERIMENTAL
Intervention: 4-band RPE
Number of subjects: 28

Group type: COMPARATOR
Intervention: 2-band RPE
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both appliances
Number of subjects: 28
Study: 12013198

Group type: EXPERIMENTAL
Intervention: 20% glycerin cream
Number of subjects: 197

Group type: COMPARATOR
Intervention: 4% urea and 4% sodium chloride cream
Number of subjects: 197

Group type: COMPARATOR
Intervention: cream base without glycerin (placebo)
Number of subjects: 197
Study: 10405732

Group type: EXPERIMENTAL
Intervention: Real acupuncture at acupoints ST.36 and LI.4
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control stimulations (minimal acupuncture and superficial pricking)
Number of subjects: 18
Study: 7752049

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine stress echocardiography
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Thallium-201 (201Tl) scintigraphy with reinjection
Number of subjects: 21
Study: 2265339

Group type: EXPERIMENTAL
Intervention: Full silicone catheters
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Hydrogel-coated latex catheters
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Siliconised latex catheters
Number of subjects: 77
Study: 475432

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (15-20 mg/kg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Oral paracetamol (15-20 mg/kg)
Number of subjects: 37
Study: 30642528

Group type: EXPERIMENTAL
Intervention: Sit-stand workstation plus advice with exercise (n=16)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sit-stand workstation plus advice without exercise (n=13)
Number of subjects: 29
Study: 28654682

Group type: EXPERIMENTAL
Intervention: Guided self-help (written CBT materials with limited telephone or face-to-face support)
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Computerised CBT (cCBT; web-based CBT materials and limited telephone support)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Waiting list for therapist-led CBT (treatment as usual)
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Overall access to high-intensity CBT
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 473
Study: 25782585

Group type: EXPERIMENTAL
Intervention: Upper cervical manipulative therapy in addition to a multimodal program
Number of subjects: 120
Study: 23886091

Group type: COMPARATOR
Intervention: Radiation therapy (R group)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Surgery plus postoperative radiation (SR group)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Both groups (R and SR)
Number of subjects: 77
Study: 21256997

Group type: EXPERIMENTAL
Intervention: Prehospital ECG utilization with audible voice alarm in the emergency department
Number of subjects: 4219

Group type: COMPARATOR
Intervention: Standard care (ECG after hospital arrival)
Number of subjects: 4219

Group type: EXPERIMENTAL
Intervention: Prehospital ECG utilization
Number of subjects: 4219
Study: 19651574

Group type: EXPERIMENTAL
Intervention: Stepped intervention (reminder postcards, telephone reminders, intensive case management)
Number of subjects: 811
Study: 17519263

Group type: EXPERIMENTAL
Intervention: Fentanyl ITS (40.0 microg fentanyl over 10 min)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Morphine PCIA (bolus doses for < or =72 h)
Number of subjects: 660